Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Work In Process (2017 - 2023)

Perspective Therapeutics' Work In Process history spans 11 years, with the latest figure at $616000.0 for Q1 2023.

  • For Q1 2023, Work In Process rose 73.52% year-over-year to $616000.0; the TTM value through Mar 2023 reached $616000.0, up 73.52%, while the annual FY2022 figure was $636000.0, N/A changed from the prior year.
  • Work In Process for Q1 2023 was $616000.0 at Perspective Therapeutics, down from $636000.0 in the prior quarter.
  • Across five years, Work In Process topped out at $636000.0 in Q4 2022 and bottomed at $114000.0 in Q1 2019.
  • The 5-year median for Work In Process is $240000.0 (2020), against an average of $306000.0.
  • The largest annual shift saw Work In Process decreased 25.49% in 2019 before it soared 129.1% in 2022.
  • A 5-year view of Work In Process shows it stood at $166000.0 in 2019, then grew by 26.51% to $210000.0 in 2020, then skyrocketed by 37.14% to $288000.0 in 2021, then surged by 120.83% to $636000.0 in 2022, then fell by 3.14% to $616000.0 in 2023.
  • Per Business Quant, the three most recent readings for CATX's Work In Process are $616000.0 (Q1 2023), $636000.0 (Q4 2022), and $614000.0 (Q3 2022).